To Evaluate the Beneficial Effect of Probiotics on DKD Patients and the Role of Gut Microbiota Modulation

NCT05674981 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

DIETARY_SUPPLEMENT: Probiotic group
OTHER: Placebo group

Sponsor

GenMont Biotech Incorporation

Collaborators

[object Object]